Earnings Feed
Start Free
Home/Filings/4/0001140361-13-010902
4//SEC Filing

GREGORY JOHN M 4

Accession 0001140361-13-010902

CIK 0001159019other
View on SEC.govCompany Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 11:18 AM ET

Size

20.9 KB

Accession

0001140361-13-010902

Insider Transaction Report

Form 4
Period: 2013-03-04
Tribute Pharmaceuticals Canada Inc.TBUFF
GREGORY JOHN M
Director10% Owner
Transactions
  • Purchase

    Common Shares

    2013-03-04+625,000→ 625,000 total
  • Purchase

    Common Shares

    2013-03-04+1,250,000→ 6,438,794 total(indirect: Affiliate)
  • Purchase

    Common Shares

    2013-03-04+625,000→ 1,025,000 total(indirect: Kingsway Charities)
  • Purchase

    Series A Common Stock Warrants (right to buy)

    2013-03-04+312,500→ 312,500 total
    Exercise: $0.50From: 2013-03-04Exp: 2015-03-04→ Common Stock (312,500 underlying)
  • Purchase

    Series B Common Stock Warrants (right to buy)

    2013-03-04+312,500→ 312,500 total
    Exercise: $0.60From: 2013-03-04Exp: 2018-03-04→ Common Stock (312,500 underlying)
  • Purchase

    Series A Common Stock Warrants (right to buy)

    2013-03-04+625,000→ 625,000 total(indirect: Affiliate)
    Exercise: $0.50From: 2013-03-04Exp: 2015-03-04→ Common Stock (625,000 underlying)
  • Purchase

    Series B Common Stock Warrants (right to buy)

    2013-03-04+625,000→ 625,000 total(indirect: Affiliate)
    Exercise: $0.60From: 2013-03-04Exp: 2018-03-04→ Common Stock (625,000 underlying)
  • Purchase

    Series A Common Stock Warrants (right to buy)

    2013-03-04+312,500→ 312,500 total(indirect: Kingsway Charities)
    Exercise: $0.50From: 2013-03-04Exp: 2015-03-04→ Common Stock (312,500 underlying)
  • Purchase

    Series B Common Stock Warrants (right to buy)

    2013-03-04+312,500→ 312,500 total(indirect: Kingsway Charities)
    Exercise: $0.60From: 2013-03-04Exp: 2018-03-04→ Common Stock (312,500 underlying)
Footnotes (1)
  • [F1]The reported securities are included within Units purchased by the reporting person for $0.40 per Unit. Each Unit consists of one share of common stock, a Series A Warrant to purchase 1/2 a share of common stock, and a Series B Warrant to purchase 1/2 a share of common stock.

Documents

1 file

Issuer

Tribute Pharmaceuticals Canada Inc.

CIK 0001159019

→
Entity typeother

Related Parties

1
  • filerCIK 0001200376

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 11:18 AM ET
Size
20.9 KB
View on SEC.gov